Indonesia's leading telehealth and health-tech platform
Halodoc is building the digital health infrastructure for Indonesia's 275 million people, many of whom lack easy access to quality healthcare.
Halodoc is a key company within the Healthtech & Biotech channel.Its official updates regularly contribute to how users track developments in this space, including strategic moves, partnerships, and technology shifts.
2 signals tracked to date in this channel.
View channelHalodoc operates in a global market where SigFact tracks official signals from primary sources to provide timely, verified intelligence.
See recent signals in this marketThis article is a commentary on the potential impact of AI on the job market and does not describe a concrete new development from a specific entity.
Halodoc Launches AI Health Assistant HILDA to Offer Initial User Guidance
This article provides a general commentary on the potential impact of artificial intelligence on the job market, without reporting any specific new developments.
Halodoc Reaches 35 Million Monthly Active Users, Launches AI Triage in Indonesia
This article provides a general commentary on the potential impact of artificial intelligence on the job market, without reporting any specific new developments.
Halodoc Reaches 35 Million Monthly Active Users, Launches AI Triage in Indonesia
Indonesian healthtech platform Halodoc has reached 35 million monthly active users and launched an AI-powered triage system that helps patients identify symptoms and route them to appropriate specialists. The AI triage system, developed in partnership with local medical institutions, supports Bahasa Indonesia and handles over 500,000 consultations per day.
This article is a commentary on the potential impact of AI on the job market and does not describe a concrete new development from a specific entity.
Halodoc Launches AI Health Assistant HILDA to Offer Initial User Guidance
Halodoc has launched an AI-powered health assistant, HILDA, to provide initial user guidance and healthcare information, particularly during off-peak hours. This initiative aims to enhance healthcare accessibility in Southeast Asia by leveraging technology to complement professional medical advice.
Major Japanese pharma company focused on urology, oncology, and transplantation
Anglo-Swedish pharma company with strong oncology and rare disease pipeline
China's largest global biotech company focused on innovative oncology medicines
India's largest biopharmaceutical company and global biosimilars leader
Digital therapeutics and remote patient monitoring platform
Global biotech leader in plasma-derived therapies and vaccines
Follow this company, add it to your watchlist, or explore its signal stream to stay informed.